167 related articles for article (PubMed ID: 17130378)
1. An uncontrolled trial of cytisine (Tabex) for smoking cessation.
Zatonski W; Cedzynska M; Tutka P; West R
Tob Control; 2006 Dec; 15(6):481-4. PubMed ID: 17130378
[TBL] [Abstract][Full Text] [Related]
2. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
[TBL] [Abstract][Full Text] [Related]
3. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
[TBL] [Abstract][Full Text] [Related]
4. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Lindson-Hawley N; Thomas KH; Fanshawe TR; Lancaster T
Cochrane Database Syst Rev; 2016 May; 2016(5):CD006103. PubMed ID: 27158893
[TBL] [Abstract][Full Text] [Related]
5. Cytisine versus nicotine for smoking cessation.
Walker N; Howe C; Glover M; McRobbie H; Barnes J; Nosa V; Parag V; Bassett B; Bullen C
N Engl J Med; 2014 Dec; 371(25):2353-62. PubMed ID: 25517706
[TBL] [Abstract][Full Text] [Related]
6. Cytisine for smoking cessation: a literature review and a meta-analysis.
Etter JF
Arch Intern Med; 2006 Aug 14-28; 166(15):1553-9. PubMed ID: 16908787
[TBL] [Abstract][Full Text] [Related]
7. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2008 Jul; (3):CD006103. PubMed ID: 18646137
[TBL] [Abstract][Full Text] [Related]
8. Cytisine for smoking cessation: a research agenda.
Etter JF; Lukas RJ; Benowitz NL; West R; Dresler CM
Drug Alcohol Depend; 2008 Jan; 92(1-3):3-8. PubMed ID: 17825502
[TBL] [Abstract][Full Text] [Related]
9. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2007 Jan; (1):CD006103. PubMed ID: 17253581
[TBL] [Abstract][Full Text] [Related]
10. Study protocol for a non-inferiority trial of cytisine versus nicotine replacement therapy in people motivated to stop smoking.
Walker N; Howe C; Bullen C; McRobbie H; Glover M; Parag V; Williman J; Veale R; Nosa V; Barnes J
BMC Public Health; 2011 Nov; 11():880. PubMed ID: 22104038
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness, safety and cost-effectiveness of cytisine versus varenicline for smoking cessation in an Australian population: a study protocol for a randomized controlled non-inferiority trial.
Thomas D; Farrell M; McRobbie H; Tutka P; Petrie D; West R; Siahpush M; Gartner C; Walker N; Mendelsohn CP; Hall W; Paul C; Zwar N; Ferguson SG; Boland VC; Richmond R; Doran CM; Shakeshaft A; Mattick RP; Courtney RJ
Addiction; 2019 May; 114(5):923-933. PubMed ID: 30589984
[TBL] [Abstract][Full Text] [Related]
12. Effect of Cytisine vs Varenicline on Smoking Cessation: A Randomized Clinical Trial.
Courtney RJ; McRobbie H; Tutka P; Weaver NA; Petrie D; Mendelsohn CP; Shakeshaft A; Talukder S; Macdonald C; Thomas D; Kwan BCH; Walker N; Gartner C; Mattick RP; Paul C; Ferguson SG; Zwar NA; Richmond RL; Doran CM; Boland VC; Hall W; West R; Farrell M
JAMA; 2021 Jul; 326(1):56-64. PubMed ID: 34228066
[TBL] [Abstract][Full Text] [Related]
13. What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation.
Leaviss J; Sullivan W; Ren S; Everson-Hock E; Stevenson M; Stevens JW; Strong M; Cantrell A
Health Technol Assess; 2014 May; 18(33):1-120. PubMed ID: 24831822
[TBL] [Abstract][Full Text] [Related]
14. Cytisine versus varenicline for smoking cessation for Māori (the indigenous people of New Zealand) and their extended family: protocol for a randomized non-inferiority trial.
Walker N; Smith B; Barnes J; Verbiest M; Kurdziel T; Parag V; Pokhrel S; Bullen C
Addiction; 2019 Feb; 114(2):344-352. PubMed ID: 30276931
[TBL] [Abstract][Full Text] [Related]
15. [Drugs used to treat nicotine addiction].
Zieleń I; Sliwińska-Mossoń M; Milnerowicz H
Przegl Lek; 2012; 69(10):1098-102. PubMed ID: 23421099
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.
Moolchan ET; Robinson ML; Ernst M; Cadet JL; Pickworth WB; Heishman SJ; Schroeder JR
Pediatrics; 2005 Apr; 115(4):e407-14. PubMed ID: 15805342
[TBL] [Abstract][Full Text] [Related]
17. Cytisine for smoking cessation in patients with tuberculosis: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.
Dogar O; Keding A; Gabe R; Marshall AM; Huque R; Barua D; Fatima R; Khan A; Zahid R; Mansoor S; Kotz D; Boeckmann M; Elsey H; Kralikova E; Parrott S; Li J; Readshaw A; Sheikh A; Siddiqi K;
Lancet Glob Health; 2020 Nov; 8(11):e1408-e1417. PubMed ID: 33069301
[TBL] [Abstract][Full Text] [Related]
18. Cytisine for nicotine addiction treatment: a review of pharmacology, therapeutics and an update of clinical trial evidence for smoking cessation.
Tutka P; Vinnikov D; Courtney RJ; Benowitz NL
Addiction; 2019 Nov; 114(11):1951-1969. PubMed ID: 31240783
[TBL] [Abstract][Full Text] [Related]
19. [Safety of nicotine addiction treatment].
Korzeniowska K; Cieślewicz A; Jabłecka A
Przegl Lek; 2013; 70(10):839-41. PubMed ID: 24501808
[TBL] [Abstract][Full Text] [Related]
20. Cytisine--a tobacco treatment hiding in plain sight.
Rigotti NA
N Engl J Med; 2014 Dec; 371(25):2429-30. PubMed ID: 25517710
[No Abstract] [Full Text] [Related]
[Next] [New Search]
